and in adults with type 2 diabetes mellitus. See Safety Info. which may affect their blood glucose. Click here for Full Prescribing Information for Lantus. starting dose for your patients with type 2 diabetes. See Safety Info. are rounded down to the nearest whole unit. (From Lantus® Prescribing Information.) . See Safety Info. or innovator, product; Currently, there are no FDA- approved AB/AP-rated follow-on biologic insulins1 More info on follow-on biologics +.
|Published (Last):||9 August 2005|
|PDF File Size:||9.61 Mb|
|ePub File Size:||13.6 Mb|
|Price:||Free* [*Free Regsitration Required]|
Your healthcare provider will decide which insulin is best for you during your pregnancy. Do not make any lantus prescribing information changes unless your healthcare provider tells ijformation to. Recapping the needle can lead to a needle stick injury. If you are a consumer or patient please visit this version.
Because animal reproduction studies are not always predictive of human response, this drug should be used during lantus prescribing information only if the potential benefit prescribjng the potential risk to the fetus.
It may harm them. Always attach a new lantus prescribing information before use. You can reduce the chance of getting an injection site reaction if you change rotate the injection site each time.
Talk to your healthcare provider if lantus prescribing information change your diet so that you know how to adjust your LANTUS and other insulin doses. In clinical studies, there was no clinically unformation difference in insulin glargine absorption after abdominal, deltoid, or thigh subcutaneous administration.
Contact your healthcare professional for further information. To avoid medication errors between LANTUS and other insulins, patients should be instructed to always verify the lantus prescribing information label before each injection.
Put your used needles and syringes in a FDA-cleared sharps disposal container right away after use.
Use intravenous, short-acting insulin instead. A metabolism study in humans indicates that insulin glargine is partly metabolized at the carboxyl terminus of the B chain in the subcutaneous depot to form two active metabolites with in vitro lantus prescribing information similar to that of human insulin, M1 21 A -Gly-insulin and M2 21 A -Gly-des B -Thr-insulin.
Do lantus prescribing information use it after this time. Lantus is a clear insulin. The mean BMI was approximately This background risk is increased in pregnancies complicated by hyperglycemia and may be decreased with good metabolic control.
Careful monitoring of glucose control is essential in these patients.
Dosing | BASAGLAR (insulin glargine injection)
This profile allows once-daily informstion as a basal insulin. LANTUS will not work if it is mixed or diluted and you may lose blood sugar control, which could be serious. The opened in-use SoloStar device lantus prescribing information be discarded 28 days after being opened. Similar effects on HbA1c Table 9 and the incidence of hypoglycemia were observed in both treatment groups [See Adverse Reactions lantus prescribing information.
Always have a spare SoloStar in case your SoloStar is lost or damaged. Lantus prescribing information kind of insulin Pen should I use? Choosing your injection site: In a combined fertility and prenatal and postnatal study in male and female rats at subcutaneous doses up to 0. However, some studies with human insulin have shown increased circulating levels of insulin in patients with renal failure.
If you have hypoglycemia often or it is hard for you to know if lantus prescribing information have the symptoms of hypoglycemia, talk to your healthcare provider. We’re sorry, lantus prescribing information site is intended for US healthcare professionals only. Figure 1 shows results from a study in patients with type 1 diabetes conducted for a maximum of 24 hours after the injection.
You can show this list to your healthcare provider anytime you get a new medicine or refill.
DailyMed – LANTUS – insulin glargin injection, solution
The objective lantus prescribing information the trial was to demonstrate that LANTUS use could significantly lower the risk of major cardiovascular outcomes compared to standard care. Check that the Cartridge System is firmly clicked in.
Hypoglycemia low blood sugar: If you would like to learn more about our companies, please visit Lilly. No patients in the other two arms discontinued for this reason. Subcutaneous reproduction and teratology studies have been performed lantus prescribing information insulin glargine and regular human insulin in rats and Himalayan rabbits. Although studies have not been performed in patients with diabetes and hepatic impairment, a reduction in the LANTUS dose may be required in patients with hepatic impairment because of reduced capacity for gluconeogenesis and reduced insulin metabolism, similar to observations found with other insulins.
FDA Internet Application Site (Accessdata) Error
Hypoglycemia, allergic reactions, injection site reaction, lipodystrophy, pruritus, and rash. Clean it once a week. Before each injection, carry out the Safety Test Step 3.